Phase 4 N=70 The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
Knee Osteoarthritis
Primary: 30 Second Chair Standing Test — 9.5 stands
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=51 Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML
ECG · Pharmacokinetics · Safety
Primary: Change From Baseline in Corrected QT Interval for Heart Rate Using Fridericia's Formula (QTcF) at Cycle 1 Day 1: 1 Hour — 4.90 milliseconds
Phase 4 N=144 A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections
Clostridium Difficile Infection (CDI)
Primary: Clinical Cure: Resolution of Diarrhea — 54; 44 Participants — p=0.195
Phase 4 N=17 Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
Pain, Intractable · Breakthrough Pain · Chronic Pain
Primary: Change From Baseline in the Numerical Rating Pain Scale (NRS) — 1.87; 1.81 units on a scale
Phase 4 N=88 Gabapentin for Alcohol Withdrawal Syndrome
Alcohol Withdrawal Syndrome
Primary: Mean Length of Hospital Stay — 44.91; 50.50 hours
Phase 4 N=110 Ketamine Versus Fentanyl for Surgical Abortions
Abortion in First Trimester · Pain, Procedural · Opioid Use
Primary: Satisfaction With Anesthesia Assessed by the ISAS — 2.4; 2.2 score on a scale
Phase 4 N=37 The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
Dry Eye Disease
Primary: IVCM for Density of Corneal Immune Dendritiform Cells — 9.47; 28.60 cells/mm^2
Phase 4 N=442 Supervised Asthma Medication in Schools (SAMS)
Childhood Asthma
Primary: The Primary Outcome Will be the Score on the Juniper Asthma Control Questionnaire (ACQ) — 54; 70; 74; 95 Participants
Phase 4 N=132 Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Obesity
Primary: Percentage of Participants Losing at Least 5% Enrollment Body Weight Measured Using Cochran-Mantel-Haenszel (CMH) Test — 76; 17 percentage of participants
Phase 4 N=65 A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
Migraine
Primary: Change From Baseline in Colonic Transit Time (CTT) at Week 2 — 5.752; -5.348 hours
Phase 4 N=30 Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
Erythematotelangiectatic Rosacea
Primary: Clinical Erythema Assessment (CEA) Score At 6-Month Post-Baseline — 1.6; 2.4 score on a scale
Phase 4 N=125 Development of Childhood Anti-Influenza Immunity
Influenza · Influenza Immunisation
Primary: Frequency of CD4 T Cells With a Given Functional Potential — 0.70; 0.55; 0.52; 0.38 Percentage
Phase 4 N=50 BPO vs Hibiclens Soap for Surgical Preparation
Propionibacterium Acnes
Primary: Number of Patients With a Positive Propionibacteria Swabs on Day of Surgery After At-Home Washes With Benzoyl Peroxide or Chlorhexidine Gluconate — 25; 24; 14; 11…
Phase 4 N=100 Tranexamic Acid in Surgery of Advanced Ovarian Cancer
Ovarian Cancer
Primary: Perioperative Bleeding Volume — 520; 730 milliliter — p=0.03
Phase 4 N=75 The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Major Depression · Bipolar I Disorder · Bipolar II Disorder
Primary: Clinical Remission of Depression — 39 Participants